Hovione presents the most comprehensive three-part webinar series on "Opportunities, Challenges and Success in Implementing Continuous Tableting – From R&D to Commercial Manufacturing".

Over the course of this series, Hovione experts and invited speakers from Merck Sharpe & Dohme, Vertex Pharmaceuticals and GEA Group will guide you through the journey of continuous manufacturing (CM) of oral solid dosage forms, also known as continuous tableting (CT), aiming to highlight key opportunities, successes, and challenges with continuous tableting. 

The content of the webinars will cover the role of CM along a wide breadth of the CMC journey, starting with lean and model-based development and concluding with commercial implementation of continuous tableting processes. 

Each session in the series will be presented as a joint talk with participants from innovators like Merck and Vertex Pharmaceuticals, and Hovione, highlighting experiences from each organization and the many advantages of a partnership-based approach. The webinar series will conclude with a final joint talk between GEA Group and Hovione announcing exciting joint innovations in the CT equipment space along with the latest advances in technology simplification.

Featured experts will be available to answer audience questions during a live Q&A after each talk.

Find out today if continuous tableting is right for your product. 

The Future is Continuous.